| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |